Fulcrum Therapeutics Inc Sustainability Reports
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules for patients with genetically defined rare diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00DDY1RM7
3 reports from 2020 to 2024
Company Profile
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules for patients with genetically defined rare diseases.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
